AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30235384
Drug: Topical Epidermal
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Epidermal Growth Factor (EGF) serum applied twice daily for eight weeks
Trial: 30235384
Drug: Placebo applied
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo applied twice daily for eight weeks
Trial: 30235384
Drug: Topical Epidermal
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Epidermal Growth Factor (EGF) serum
Trial: 17230307
Drug: Subcutaneous anterior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous anterior transposition of the nerve
Trial: 12198065
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg IM phenylephrine
Trial: 12198065
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg IM phenylephrine
Trial: 9989959
Drug: Automated heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated heparin control system (AutoHep) with initial bolus of heparin
Trial: 9989959
Drug: Automated heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated heparin control system (AutoHep) without initial bolus of heparin
Trial: 1730312
Drug: Conventional infertility
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional infertility treatment (induction of ovulation with gonadotropins followed by intrauterine artificial insemination or normal intercourse)
Trial: 3548009
Drug: Butorphanol 2
RxNorm normalized name: butorphanol 2 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol 2 mg
Trial: 31008635
Drug: Preventive cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive cognitive therapy (PCT), 8 weekly sessions
Trial: 29421065
Drug: 8% topical
RxNorm normalized name: BPO 8% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% topical capsaicin
Trial: 15656211
Drug: GnRH analogue
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH analogue (leuprolide acetate, 3.75 mg, intramuscular injections every 28 days for 3 months)
Trial: 15656211
Drug: Danazol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol (400 mg orally, 2 times per day for 3 months)
Trial: 15656211
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no postoperative treatment, underwent ovarian stimulation immediately after first menses within 3 months postoperatively)
Trial: 9192396
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss in the first four weeks and daily food records completion
Trial: 23146280
Drug: Adjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant treatment with paclitaxel (E-T-CMF)
Trial: 23146280
Drug: Adjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant treatment with epirubicin followed by CMF (E-CMF)
Trial: 20703222
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg intravenous dose of rifampin
Trial: 20703222
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg dose of warfarin alone
Trial: 10406365
Drug: Better pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Better pain treatment
Trial: 2135070
Drug: Pyritinol 600
RxNorm normalized name: pyritinol
DrugBank: Pyritinol (DB13084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyritinol 600 mg
Trial: 2135070
Drug: Pyritinol 1200
RxNorm normalized name: pyritinol
DrugBank: Pyritinol (DB13084)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyritinol 1200 mg
Trial: 378623
Drug: Oral L-dopa
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral L-dopa 1000 mg
Trial: 378623
Drug: L-dopa placebo
RxNorm normalized name: α-methyl-L-dopa
DrugBank: Methyldopa (DB00968)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-dopa placebo
Trial: 22264208
Drug: 1% Alendronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% Alendronate (ALN) gel
Trial: 27091596
Drug: 1.2% Atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2% Atorvastatin (ATV) gel
Trial: 31318225
Drug: Individualized assessment
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized assessment and treatment program (IATP)
Trial: 17387131
Drug: Atorvastatin combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin combined with 60 mg of torcetrapib for 2 years
Trial: 15492573
Drug: 40 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mL/kg intraoperative administration of lactated Ringer's solution (LR)
Trial: 15492573
Drug: 15 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mL/kg intraoperative administration of lactated Ringer's solution (LR)
Trial: 11446476
Drug: Enoxaparin 2,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 2,500 IU once daily
Trial: 11446476
Drug: Standard Heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Heparin 5,000 IU three times daily
Trial: 9572995
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) 400 microg/m2 IV over 30 minutes once daily
Trial: 8071389
Drug: Ciprofloxacin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (500 mg twice daily for 4 days)
Trial: 8071389
Drug: Temazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam (10 mg single oral dose)
Trial: 3342282
Drug: Liquid formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid formulation of benzydamine hydrochloride with ICEBERG AR 84/05/15 flavoring agent
Trial: 3342282
Drug: Liquid formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid formulation of benzydamine hydrochloride without ICEBERG AR 84/05/15 flavoring agent
Trial: 31882376
Drug: Alirocumab (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab (75 mg every 2 weeks, with dose increase to 150 mg every 2 weeks at week 12 if week 8 LDL-C was >1.81 mmol/L)
Trial: 29266308
Drug: PF-06700841 30
RxNorm normalized name: PF-06700841
DrugBank: PF-06700841 (DB15003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06700841 30 mg once daily
Trial: 29266308
Drug: PF-06700841 100
RxNorm normalized name: PF-06700841
DrugBank: PF-06700841 (DB15003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06700841 100 mg once daily
Trial: 29266308
Drug: PF-06700841 (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PF-06700841 (various doses)
Trial: 25119580
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment with warning about side effects
Trial: 25119580
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment without warning about side effects
Trial: 25119580
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment with warning about side effects
Trial: 25119580
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment without warning about side effects
Trial: 23672267
Drug: rhANP 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhANP 0.1 μg/kg/min
Trial: 23672267
Drug: rhANP 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhANP 0.2 μg/kg/min
Trial: 23672267
Drug: rhANP 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhANP 0.05 μg/kg/min
Trial: 20439384
Drug: School-based nurse-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: School-based nurse-directed smokeless tobacco cessation intervention including peer-led educational sessions and oral exams by the school nurse with brief tobacco cessation counseling.
Trial: 18520292
Drug: Bevacizumab at
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab at 15 mg/kg every 3 weeks
Trial: 18520292
Drug: Bevacizumab at
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bevacizumab at 7.5 or 15 mg/kg every 3 weeks
Trial: 12687554
Drug: Alendronate (ALN)
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate (ALN) discontinued (<90 days of therapy)
Trial: 10227337
Drug: Salmeterol (42
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (42 microg twice daily)
Trial: 10400478
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) (84 microg four times daily)
Trial: 8911782
Drug: Purified micronized
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified micronized flavonoid fraction (Daflon 500 mg)
Trial: 1868678
Drug: ciprofloxacin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ciprofloxacin (750 mg every 12 hours for five doses)
Trial: 1868678
Drug: temafloxacin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: temafloxacin (600 mg every 12 hours for five doses)
Trial: 1868678
Drug: placebo (given
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo (given every 12 hours for five doses)
Trial: 31977858
Drug: Vicagrel 5
RxNorm normalized name: Vicagrel
DrugBank: Vicagrel (DB16349)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicagrel 5 mg
Trial: 30326264
Drug: Vicagrel 20
RxNorm normalized name: Vicagrel
DrugBank: Vicagrel (DB16349)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicagrel 20 mg
Trial: 30326264
Drug: Vicagrel 25
RxNorm normalized name: Vicagrel
DrugBank: Vicagrel (DB16349)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vicagrel 25 mg
Trial: 15612841
Drug: Naturally occurring
RxNorm normalized name: Naturally occurring alkaloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naturally occurring (NO) marriage preparation
Trial: 11352439
Drug: Calcium 500mg
RxNorm normalized name: CALCIUM 500MG TAB
DrugBank: Calcium sulfate (DB15533)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium 500mg (Calcium‐Sandoz Forte) administered before, and 12 and 24 hours after moxifloxacin
Trial: 9164427
Drug: buspirone 30
RxNorm normalized name: busPIRone 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buspirone 30 mg daily
Trial: 8220803
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 micrograms once daily
Trial: 8220803
Drug: Budesonide 200
RxNorm normalized name: budesonide 200 mcg/inh inhalation powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 200 micrograms once daily
Trial: 26285691
Drug: Nebivolol 10
RxNorm normalized name: nebivolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol 10 mg daily
Trial: 26285691
Drug: Metoprolol succinate
RxNorm normalized name: Metoprolol Succinate
DrugBank: Metoprolol (DB00264)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol succinate 100 mg daily
Trial: 20555272
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment groups (DD and RB)
Trial: 9625841
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy in NSCLC (14 patients)
Trial: 9625841
Drug: Systemic chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic chemotherapy in SCLC (9 patients)
Trial: 3286783
Drug: Norfloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (400 mg) every 12 hours for 28 days
Trial: 22940254
Drug: Herbal medicines
RxNorm normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Herbal medicines only (57 patients)
Trial: 22940254
Drug: Herbal and
RxNorm normalized name: ALLANTOIN 1 g in 100 g TOPICAL CREAM [Scar Reducer Intensive Herbal and Nutrient]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal and conventional medicines concurrently (256 patients)
Trial: 20729255
Drug: Synbiotic preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotic preparation (Lactobacillus helveticus R0052, Bifidobacterium infantis R0033, Bifidobacterium bifidum R0071, and fructooligosaccharide)
Trial: 2852948
Drug: Chemotherapy (cisplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (cisplatin and etoposide)
Trial: 31880479
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of treatment with 36 or 54 mg extended release methylphenidate for 7 weeks
Trial: 28627070
Drug: Hydrolysed wheat
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrolysed wheat flour (10 g of gluten/d for 3 days)
Trial: 28627070
Drug: Natural wheat
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural wheat flour (10 g of gluten/d for 3 days)
Trial: 26545731
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Entonox and play therapy
Trial: 17435692
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg intravitreal triamcinolone acetonide injection
Trial: 14518703
Drug: Twice-a-day low-pill
RxNorm normalized name: Aspir-Low Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-a-day low-pill burden regimen (EFV+Combivir)
Trial: 14518703
Drug: Twice-a-day high-pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice-a-day high-pill burden regimen (NFV+Combivir)
Trial: 10606833
Drug: Inhaled rac-salbutamol
RxNorm normalized name: rac-dobutamine
DrugBank: Dobutamine (DB00841)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled rac-salbutamol (1200 microg) with oral charcoal
Trial: 10606833
Drug: Intravenous rac-salbutamol
RxNorm normalized name: rac-dobutamine
DrugBank: Dobutamine (DB00841)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous rac-salbutamol (500 microg)
Trial: 2868579
Drug: i.v. famotidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. famotidine 10 mg every 6-12 hours for maximally seven days
Trial: 31146740
Drug: MCT oil
RxNorm normalized name: Organic MCT Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MCT oil supplement (9% metabolic energy based calculated)
Trial: 31146740
Drug: Control dietary
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control dietary supplement (DS)
Trial: 26455674
Drug: Imagery Rehearsal
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imagery Rehearsal Therapy (IRT) consisting of 6 individual sessions
Trial: 18982437
Drug: 3-week oral
RxNorm normalized name: etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3-week oral anticoagulation therapy (OACs) before heparin bridging
Trial: 18982437
Drug: No prior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prior oral anticoagulation therapy (N-OACs)
Trial: 14971670
Drug: Adrenaline and
RxNorm normalized name: Adrenaline and zinc only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline and saline infiltration (2.5 mg of 1:1000 adrenaline diluted in 500 mL of normal saline)
Trial: 11801508
Drug: Latanoprost once
RxNorm normalized name: Latanoprost
DrugBank: Latanoprost (DB00654)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Latanoprost once daily
Trial: 11167277
Drug: Timolol plus
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol plus dorzolamide twice daily
Trial: 28711629
Drug: Pre-procedure rectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-procedure rectal swabs
Trial: 23921338
Drug: PRP-augmented treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP-augmented treatment
Trial: 19454547
Drug: Aprepitant (NK1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aprepitant (NK1 receptor antagonist)
Trial: 19454547
Drug: Other NK1
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other NK1 receptor antagonists (under investigation)
Trial: 15058213
Drug: Wenshen Xiezhuo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wenshen Xiezhuo Decoction (WSXZD) plus low-protein diets, controlling hypertension, and symptomatic treatment
Trial: 15058213
Drug: Low-protein diets,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diets, controlling hypertension, and symptomatic treatment
Trial: 2328561
Drug: Buprenorphine daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine daily administration (8 mg)
Trial: 2328561
Drug: Buprenorphine alternate-day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine alternate-day administration
Trial: 28042054
Drug: Tight glycemic
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tight glycemic control with a blood glucose target range of 80-110 mg/dL (4.4-6.1 mmol/L)
Trial: 28042054
Drug: Standard glycemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard glycemic control with a blood glucose target range of 150-180 mg/dL (8.3-10.0 mmol/L)
Trial: 26747421
Drug: Probiotic milk
RxNorm normalized name: PROBIOTIC
DrugBank: Bifidobacterium longum (DB19248)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic milk (150 mL of milk supplemented with Lactobacillus rhamnosus SP1 at 10(7) CFU/mL)
Trial: 24256479
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy with self-hypnosis (7 sessions)
Trial: 24256479
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy without self-hypnosis (11 sessions)
Trial: 17768103
Drug: Enzyme inhibitor
RxNorm normalized name: Enzyme inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzyme inhibitor Dx‐88
Trial: 17768103
Drug: Receptor antagonist
RxNorm normalized name: H2-receptor antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Receptor antagonist Icatibant
Trial: 15831784
Drug: Azacitidine administered
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine administered as a single 75‐mg/m(2) SC dose
Trial: 15831784
Drug: Azacitidine administered
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine administered as a single 75‐mg/m(2) IV infusion dose over 10 minutes
Trial: 11979401
Drug: Margarine with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Margarine with sterol esters (MSE; 1.92 g/d)
Trial: 11979401
Drug: Margarine with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Margarine with stanol esters (MSA; 1.76 g/d)
Trial: 9882991
Drug: Rokitamycin, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rokitamycin, 400 mg tablet every 12 hours for 14 days
Trial: 9882991
Drug: Josamycin, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Josamycin, 500 mg tablet every 8 hours for 14 days
Trial: 8564679
Drug: Midazolam (3.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (3.4 +/- 1.3 mg)
Trial: 30002871
Drug: Effective family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effective family planning (EFP) methods (injectable, oral, intra‐uterine contraceptive device, or Norplant)
Trial: 27861326
Drug: Magnetic resonance-guided
RxNorm normalized name: MAGNESIA
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnetic resonance-guided laser-induced thermal therapy (MRgLITT)
Trial: 30103529
Drug: Multiple micronutrient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple micronutrient (MMN) supplements
Trial: 25065540
Drug: Chest Physical
RxNorm normalized name: Kids-Eeze Chest Relief
DrugBank: Guaifenesin (DB00874)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chest Physical Therapy (CPT)
Trial: 20096799
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg od)
Trial: 19029420
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Nurse‐Administered Symptom Management intervention
Trial: 19029420
Drug: Single agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single agents chemotherapy
Trial: 19029420
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy protocols
Trial: 16497598
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch + stimulant medication
Trial: 16497598
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch only